A mixed-method study on antimicrobial resistance infection drivers in neonatal intensive care units: pathways, risks, and solutions
This study evaluates antimicrobial resistance (AMR) in neonatal intensive care units (NICUs) at Felege Hiwot Hospital. Out of 420 samples, 35% tested positive for AMR pathogens, with Coagulase-Negative Staphylococci, Klebsiella pneumoniae, and Acinetobacter spp. being the most prevalent. Resistance rates for Gentamicin, Cotrimoxazole, and Ciprofloxacin were alarmingly high, while Amikacin demonstrated low resistance. Risk factors such as improper PPE use, non-functional handwashing sinks, and inadequate disinfection practices were strongly associated with microbial contamination. Amikacin shows promise as an effective treatment for CONS.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!